Company Filing History:
Years Active: 1999
Title: Innovations of Hideji Hashida in Alzheimer's Disease Research
Introduction
Hideji Hashida is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of Alzheimer's disease. His innovative work has the potential to impact the lives of many patients suffering from this debilitating condition.
Latest Patents
Hashida holds a patent related to DNA and protein for the diagnosis and treatment of Alzheimer's disease. The patent describes a DNA selected from DNAs, each having the nucleotide sequence of one of Sequence Nos. 1 to 17. This DNA is complementary to the RNA strand of mRNA with varied expression levels in patients with Alzheimer's disease, compared to the expression level of the mRNA in a normal human brain. The invention also includes a polypeptide encoded by the DNA, an antibody recognizing the polypeptide, and methods for diagnosis, therapeutic treatment, and research works involving patients with Alzheimer's disease.
Career Highlights
Hashida is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. His work at the company has allowed him to focus on innovative solutions for complex medical challenges.
Collaborations
Throughout his career, Hashida has collaborated with notable colleagues, including Tetsuro Kuga and Satoshi Nakagawa. These collaborations have fostered a productive environment for research and development in the field of Alzheimer's disease.
Conclusion
Hideji Hashida's contributions to Alzheimer's disease research through his innovative patent highlight the importance of scientific advancements in healthcare. His work continues to inspire future research and development in the medical field.